GH Research (GHRS) Change in Cash (2020 - 2025)
GH Research's (GHRS) quarterly Change in Cash came in at -$3.6 million in Q4 2025, down 132.87% year-on-year from $10.8 million in Q4 2024, and up 10.24% quarter-over-quarter from -$4.0 million in Q3 2025.
GH Research (GHRS) Change in Cash (2020 - 2025) Analysis & Trends
GH Research's Change in Cash history runs 6 years deep, the most recent figure standing at -$3.6 million for Q4 2025.
- On a quarterly basis, Change in Cash fell 132.87% year-over-year to -$3.6 million in Q4 2025; TTM through Dec 2025 was $142.3 million, a 531.03% increase from a year earlier, with the FY2025 full-year figure at $142.3 million, up 531.03% from the prior year.
- Change in Cash grew to -$3.6 million in Q4 2025 per GHRS's latest filing, from -$4.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $288.0 million in Q2 2021 and bottomed at -$91.5 million in Q4 2022.
- The 5-year median for Change in Cash is -$4.0 million (2021), against an average of $11.9 million.
- Across the five-year window, Change in Cash tumbled 15309.09% in 2021 and soared 16496.25% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$3.9 million in 2021, then plunged by 2217.78% to -$91.5 million in 2022, then jumped by 91.09% to -$8.2 million in 2023, then soared by 232.83% to $10.8 million in 2024, then plunged by 132.87% to -$3.6 million in 2025.
- Per Business Quant, the three latest GHRS Change in Cash figures stand at -$3.6 million (Q4 2025), -$4.0 million (Q3 2025), and $5.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | -3.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.56 Mn |
| Sep 30, 2025 | -3.96 Mn |
| Jun 30, 2025 | 5.67 Mn |
| Mar 31, 2025 | 144.12 Mn |
| Dec 31, 2024 | 10.83 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Mar 31, 2024 | -879,000.00 |
| Dec 31, 2023 | -8.15 Mn |
| Sep 30, 2023 | -10.40 Mn |
| Jun 30, 2023 | -8.11 Mn |
| Mar 31, 2023 | -60.98 Mn |
| Dec 31, 2022 | -91.51 Mn |
| Sep 30, 2022 | -8.06 Mn |
| Jun 30, 2022 | -5.31 Mn |
| Mar 31, 2022 | -6.01 Mn |
| Dec 31, 2021 | -3.95 Mn |
| Sep 30, 2021 | -11.87 Mn |
| Jun 30, 2021 | 287.98 Mn |
| Mar 31, 2021 | -1.11 Mn |